DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ advanced 2.23% to $215.43 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,591.70 and Dow Jones Industrial Average falling 0.60% to 52,064.10.
The stock's rise snapped a three-day losing streak.
Biogen Inc. closed 4.59% below its 52-week high of $225.80, which the company reached on September 3rd.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.27% to $266.35, Pfizer Inc. $(PFE)$ fell 0.47% to $27.65, and AbbVie Inc. $(ABBV)$ rose 1.63% to $255.00.
Trading volume (928,007) remained 134,784 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.